Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21547395 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: incyclinide

Indicates status has not been verified in more than two years